{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T11:34:04Z","timestamp":1766748844051,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"MRC-KHIDI UK-KOREA PARTNERING AWARD","award":["MC_PC_16016"],"award-info":[{"award-number":["MC_PC_16016"]}]},{"name":"Southampton National Institute for Health Research Biomedical Research Centre"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.numecd.2019.01.016","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T05:28:07Z","timestamp":1549776487000},"page":"489-495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Non alcoholic fatty liver disease and risk of incident diabetes in subjects who are not obese"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6108-7758","authenticated-orcid":false,"given":"K.-C.","family":"Sung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.-C.","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.-J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.H.","family":"Wild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.D.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2019.01.016_bib1","first-page":"216","article-title":"Non-alcoholic fatty liver disease in lean subjects: characteristics and implications","volume":"5","author":"Kumar","year":"2017","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.numecd.2019.01.016_bib2","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.cgh.2016.08.028","article-title":"Nonobese fatty liver disease","volume":"15","author":"Kim","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.numecd.2019.01.016_bib3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/apt.14112","article-title":"Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients","volume":"46","author":"Sookoian","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.numecd.2019.01.016_bib4","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12664-014-0488-5","article-title":"Clinical, anthropometric, biochemical, and histological characteristics of nonobese nonalcoholic fatty liver disease patients of Bangladesh","volume":"33","author":"Alam","year":"2014","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.numecd.2019.01.016_bib5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MD.0b013e3182779d49","article-title":"Nonalcoholic fatty liver disease in lean individuals in the United States","volume":"91","author":"Younossi","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.numecd.2019.01.016_bib6","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1001\/archinte.164.19.2169","article-title":"Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults","volume":"164","author":"Kim","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.numecd.2019.01.016_bib7","doi-asserted-by":"crossref","first-page":"17932","DOI":"10.3748\/wjg.v20.i47.17932","article-title":"Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population","volume":"20","author":"Feng","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.numecd.2019.01.016_bib8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/ajg.2016.318","article-title":"Clinical and metabolic characterization of lean caucasian subjects with non-alcoholic fatty liver","volume":"112","author":"Feldman","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.numecd.2019.01.016_bib9","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/ajg.2012.314","article-title":"Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults","volume":"107","author":"Kwon","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.numecd.2019.01.016_bib10","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1111\/j.1440-1746.2012.07222.x","article-title":"Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese","volume":"27","author":"Liu","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.numecd.2019.01.016_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192663","article-title":"Insulin resistance in lean and overweight non-diabetic Caucasian adults: study of its relationship with liver triglyceride content, waist circumference and BMI","volume":"13","author":"Gonzalez-Cantero","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.numecd.2019.01.016_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep4.1124","article-title":"Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: a long-term follow-up study","volume":"2","author":"Hagstrom","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.numecd.2019.01.016_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2017.04.045","article-title":"Liver and cardiovascular damage in patients with lean nonalcoholic fatty liver disease, and association with visceral obesity","volume":"15","author":"Fracanzani","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.numecd.2019.01.016_bib14","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/dc17-1902","article-title":"Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis","volume":"41","author":"Mantovani","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2019.01.016_bib15","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.numecd.2019.01.016_bib16","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/gut.2010.216077","article-title":"Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease","volume":"59","author":"McPherson","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.numecd.2019.01.016_bib17","doi-asserted-by":"crossref","first-page":"k2734","DOI":"10.1136\/bmj.k2734","article-title":"Tests for diagnosing and monitoring non-alcoholic fatty liver disease in adults","volume":"362","author":"Byrne","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.numecd.2019.01.016_bib18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3803\/EnM.2014.29.4.405","article-title":"2014 clinical practice guidelines for overweight and obesity in Korea","volume":"29","author":"Kim","year":"2014","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/j.numecd.2019.01.016_bib19","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/gast.2002.35354","article-title":"The utility of radiological imaging in nonalcoholic fatty liver disease","volume":"123","author":"Saadeh","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.numecd.2019.01.016_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s10038-018-0420-4","article-title":"Could inherited predisposition drive non-obese fatty liver disease? Results from German tertiary referral centers","author":"Krawczyk","year":"2018","journal-title":"J Hum Genet"},{"key":"10.1016\/j.numecd.2019.01.016_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddy124","article-title":"NAFLD risk alleles in PNPLA3, TM6SF2, GCKR, and LYPLAL1 show divergent metabolic effects","author":"Sliz","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.numecd.2019.01.016_bib22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.beem.2016.06.006","article-title":"Non-alcoholic fatty liver disease and risk of type 2 diabetes","volume":"30","author":"Lallukka","year":"2016","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2019.01.016_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.hbpd.2018.01.007","article-title":"Risk factors and metabolic abnormality of patients with non-alcoholic fatty liver disease: either non-obese or obese Chinese population","volume":"17","author":"Lee","year":"2018","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.numecd.2019.01.016_bib24","first-page":"1","article-title":"The relationship between obesity and the severity of non-alcoholic fatty liver disease: systematic review and meta-analysis","author":"Lu","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.numecd.2019.01.016_bib25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2019.01.016_bib26","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa1010949","article-title":"Pioglitazone for diabetes prevention in impaired glucose tolerance","volume":"364","author":"DeFronzo","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2019.01.016_bib27","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases","author":"Chalasani","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2019.01.016_bib28","doi-asserted-by":"crossref","first-page":"i4428","DOI":"10.1136\/bmj.i4428","article-title":"Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance","volume":"354","author":"Glen","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.numecd.2019.01.016_bib29","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00125-016-3902-y","article-title":"EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"59","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2019.01.016_bib30","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2337\/dc11-1853","article-title":"Combined influence of insulin resistance, overweight\/obesity, and fatty liver as risk factors for type 2 diabetes","volume":"35","author":"Sung","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2019.01.016_bib31","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1210\/jc.2013-1519","article-title":"Resolution of fatty liver and risk of incident diabetes","volume":"98","author":"Sung","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2019.01.016_bib32","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jhep.2014.01.009","article-title":"Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension","volume":"60","author":"Sung","year":"2014","journal-title":"J Hepatol"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093947531930033X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093947531930033X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:09:17Z","timestamp":1760544557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093947531930033X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S093947531930033X"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2019.01.016","relation":{},"ISSN":["0939-4753"],"issn-type":[{"type":"print","value":"0939-4753"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non alcoholic fatty liver disease and risk of incident diabetes in subjects who are not obese","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2019.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V. on behalf of The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University.","name":"copyright","label":"Copyright"}]}}